Assyro AI is the regulatory copilot for pharma and biotech
Assyro AI is an AI-powered regulatory copilot designed to transform how pharmaceutical and biotech companies prepare and submit regulatory documentation. By combining advanced drafting assistance, real-time eCTD/RPS validation, and deep regulatory intelligence, Assyro helps teams accelerate submission timelines, minimize compliance risk, and reduce costly rework. Its platform delivers clause-level guidance and audit-ready trails tailored for drugs and biologics, enabling regulatory, publishing, and compliance leaders to draft faster, validate more efficiently, and submit with confidence.
Assyro gives regulatory teams a secure, AI-native way to move from manual, error-prone submission workflows to faster, data-driven operations that are always inspection ready. By combining clause-level regulatory intelligence with high-speed, local eCTD validation and transparent audit trails, it helps pharma and biotech organizations accelerate approvals, reduce compliance risk, and scale global submissions without adding headcount.
4.8
6 ratings
Indie Hacker
AI video with native sound, paid per clip. Nothing stored.
A calmer Mac menu bar, one click away.
Enterprise Software. Intelligent Automation. Global Impact.
Comments
3制药行业的监管合规确实是个痛点,文书工作繁琐又容易出错。Assyro 用 AI 来辅助 eCTD 验证和文书撰写这个思路很棒,能大幅提升效率。特别是条款级指导和审计追踪功能,对合规负责人来说应该很实用。希望能看到更多这样针对垂直行业的 AI 解决方案!
Precise, efficient, and compliant—Assyro is reshaping the regulatory application process with AI, enabling drug applications to move from manual verification to intelligent driving, and truly liberating regulatory teams.
CEO at CollabCRM
ohh its nice to care about other people